# 119-s-4698: Right to Try for Individualized Treatments Act

119-s-4698, Right to Try for Individualized Treatments Act, is a 119th Congress bill sponsored by Sen. Johnson, Ron [R-WI] (R-WI); status introduced; PRIA reads it as touching household money (as of 2026-07-25).

- Canonical: https://policyrisk.com/legislation/119-s-4698
- As of: 2026-07-25
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-4698
- Congress: 119
- Title: Right to Try for Individualized Treatments Act
- Status: introduced
- Introduced: 2026-06-08
- Sponsor: Sen. Johnson, Ron [R-WI] (R-WI)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-07-25

## Summary

**This bill would create two new pathways letting seriously ill patients access investigational drugs and genomic‑tailored therapies outside clinical trials.** It centers on expanded patient access to investigational individualized medical treatments while keeping physician certification and written informed consent as guardrails. - Patients and families: Patients with life‑threatening or severely debilitating conditions who have exhausted or considered approved options could receive eligible investigational drugs or individualized treatments based on their unique genomic profile. Patients must give written informed consent or have a legally authorized representative consent for them. - Treating physicians and facilities: Physicians must certify they are in good standing and must not accept direct payment from manufacturers for that certification. Eligible health care facilities must operate under federal human subject protections and physicians must provide an "additional informed consent" document with specific elements about current care, life expectancy, and risks. - Manufacturers and access rules: The bill lets manufacturers make investigational individualized medical treatments available to eligible patients but does not require them to do so. It also amends the Federal Food, Drug, and Cosmetic Act to add and align definitions and cross‑references for these treatments.

## Cosponsors (1)

- Sen. Tuberville, Tommy [R-AL] (R-AL), 2026-06-08T00:00:00.000Z

## Provisions PRIA read

- Access to experimental genetic treatments: benefit, high. If enacted, this bill would let patients with life‑threatening or severely debilitating illnesses ask drug makers for experimental treatments. It creates two access paths: one for investigational drugs after you exhaust approved options and cannot join a trial. The other path covers individualized…

## Related bills

- 119-s-3752: SAVE America Act
- 119-s-401: Fair Access to Banking Act
- 119-s-382: Dismantle DEI Act of 2025
- 119-s-587: Death Tax Repeal Act of 2025
- 119-s-186: No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025
- 119-s-6: Born-Alive Abortion Survivors Protection Act

## Sources
- [119-s-4698 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/4698)

## Related
- [119-s-3752: SAVE America Act](https://policyrisk.com/legislation/119-s-3752)
- [119-s-401: Fair Access to Banking Act](https://policyrisk.com/legislation/119-s-401)
- [119-s-382: Dismantle DEI Act of 2025](https://policyrisk.com/legislation/119-s-382)
- [119-s-587: Death Tax Repeal Act of 2025](https://policyrisk.com/legislation/119-s-587)
- [119-s-186: No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of…](https://policyrisk.com/legislation/119-s-186)
- [119-s-6: Born-Alive Abortion Survivors Protection Act](https://policyrisk.com/legislation/119-s-6)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-4698 (as of 2026-07-25).